Nipro Corp. (NPRRF)
9.96
0.00 (0.00%)
USD |
OTCM |
May 29, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.624B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 23.46% |
| Valuation | |
| PE Ratio | 20.93 |
| PE Ratio (Forward) | |
| PS Ratio | 0.4065 |
| Price to Book Value | 0.9428 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.1269 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 2.329 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. Its operations are carried out through the following segments: Medical related, Pharmaceutical related, Pharma Packaging, and Others. The Medical related segment provides injection and infusion-related products, artificial organ-related products, functional products, and dialysis and diabetes-related products. The Pharmaceutical related segment involves the manufacture and sale of injections, oral agents, and pharmaceutical kit products. The Pharma Packaging segment provides glass products for bottle tubes, ampoules, thermos-use, and lighting. The Others segment includes real estate leasing. The company was founded on July 8, 1954 and is headquartered in Osaka, Japan. |
| URL | http://www.nipro.co.jp |
| Investor Relations URL | N/A |
| HQ State/Province | Osaka |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Aug. 07, 2026 (est.) |
| Last Earnings Release | May. 12, 2026 |
| Next Ex-Dividend Date | Sep. 30, 2026 |
| Last Ex-Dividend Date | Mar. 31, 2026 |
Profile
| Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. Its operations are carried out through the following segments: Medical related, Pharmaceutical related, Pharma Packaging, and Others. The Medical related segment provides injection and infusion-related products, artificial organ-related products, functional products, and dialysis and diabetes-related products. The Pharmaceutical related segment involves the manufacture and sale of injections, oral agents, and pharmaceutical kit products. The Pharma Packaging segment provides glass products for bottle tubes, ampoules, thermos-use, and lighting. The Others segment includes real estate leasing. The company was founded on July 8, 1954 and is headquartered in Osaka, Japan. |
| URL | http://www.nipro.co.jp |
| Investor Relations URL | N/A |
| HQ State/Province | Osaka |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Aug. 07, 2026 (est.) |
| Last Earnings Release | May. 12, 2026 |
| Next Ex-Dividend Date | Sep. 30, 2026 |
| Last Ex-Dividend Date | Mar. 31, 2026 |